Ironwood Pharmaceuticals (IRWD)
Develops gastrointestinal therapies around LINZESS and apraglutide.
$4.53
After hours0.00 (0.00%)
At close$4.53(+2.72%)
Something off on this page? Send us feedback.
Next report
Nov 9, 26
in 48 days
EPS estimate
$0.30
Revenue estimate
$120.0M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$0.02−$0.23$0.14$0.24−$0.01$0.24$0.31Pending
Estimate$0.12−$0.05−$0.02$0.09$0.02$0.07$0.32$0.30
Surprise−83.3%−360.0%+800.0%+166.7%−150.0%+242.9%−3.1%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$90.5M$41.1M$85.2M$122.1M$47.7M$106.5M$113.0MPending
Estimate$93.8M$45.9M$60.8M$74.7M$50.9M$92.1M$114.8M$120.0M
Surprise−3.4%−10.4%+40.3%+63.4%−6.3%+15.6%−1.6%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $0.43 | — | — |
| Sep 2028 | $0.37 | — | — |
| Jun 2028 | $0.33 | — | — |
| Mar 2028 | $0.30 | — | — |
| Dec 2027 | $0.39 | — | — |
| Sep 2027 | $0.35 | — | — |
| Jun 2027 | $0.31 | — | — |
| Mar 2027 | $0.30 | — | — |
| Dec 2026 | $0.34 | — | — |
| Nov 2026 | $0.30 | — | — |
| Aug 2026 | $0.32 | $0.31 | −3.1% |
| May 2026 | $0.07 | $0.24 | +242.9% |
| Feb 2026 | $0.02 | −$0.01 | −150.0% |
| Nov 2025 | $0.09 | $0.24 | +166.7% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $0.43 | — | — | $147.2M | — | — | — |
| Sep 2028 | $0.37 | — | — | $132.7M | — | — | — |
| Jun 2028 | $0.33 | — | — | $122.1M | — | — | — |
| Mar 2028 | $0.30 | — | — | $114.6M | — | — | — |
| Dec 2027 | $0.39 | — | — | $140.2M | — | — | — |
| Sep 2027 | $0.35 | — | — | $126.4M | — | — | — |
| Jun 2027 | $0.31 | — | — | $116.2M | — | — | — |
| Mar 2027 | $0.30 | — | — | $109.1M | — | — | — |
| Dec 2026 | $0.34 | — | — | $128.2M | — | — | — |
| Nov 9, 2026 | $0.30 | — | — | $120.0M | — | — | — |
| Aug 6, 2026 | $0.32 | $0.31 | −3.1% | $114.8M | $113.0M | −1.6% | +2.7% |
| May 7, 2026 | $0.07 | $0.24 | +242.9% | $92.1M | $106.5M | +15.6% | −13.7% |
| Feb 25, 2026 | $0.02 | −$0.01 | −150.0% | $50.9M | $47.7M | −6.3% | −11.4% |
| Nov 10, 2025 | $0.09 | $0.24 | +166.7% | $74.7M | $122.1M | +63.4% | +31.8% |
| Aug 7, 2025 | |||||||
| May 7, 2025 | |||||||
| Feb 27, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 9, 2024 | |||||||
| Feb 15, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 8, 2023 | |||||||
| May 4, 2023 | |||||||
| Feb 16, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 5, 2022 | |||||||
| Feb 17, 2022 | |||||||
| Nov 4, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 6, 2021 | |||||||
| Feb 17, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 6, 2020 | |||||||
| May 6, 2020 | |||||||
| Feb 13, 2020 | |||||||
| Oct 31, 2019 | |||||||
| Jul 30, 2019 | |||||||
| May 2, 2019 | |||||||
| Feb 13, 2019 | |||||||
| Nov 6, 2018 | |||||||
| Aug 6, 2018 | |||||||
| May 1, 2018 | |||||||
| Feb 15, 2018 | |||||||
| Nov 2, 2017 | |||||||
| Aug 3, 2017 | |||||||
| May 8, 2017 | |||||||
| Feb 21, 2017 | |||||||
| Nov 3, 2016 | |||||||
| Aug 4, 2016 | |||||||
| May 9, 2016 | |||||||
| Feb 18, 2016 | |||||||
| Nov 3, 2015 | |||||||
| Aug 5, 2015 |